Protia Inc. (KOSDAQ: 303360)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,700.00
+50.00 (1.89%)
Nov 15, 2024, 9:00 AM KST

Protia Company Description

Protia Inc. designs, develops, and sells diagnostic kits in South Korea.

The company offers PROTIA Allergy-Q, an assay kit for quantitative determination of specific IgE antibodies against individual allergens in human serum using immunoblotting technique; ImmuneCheck IgG, a whole blood test kit for total IgG concentration measurement; and TriCheck-C, an in vitro diagnostic kit for the qualitative test of human chorionic gonadotropin in human urine samples for the pregnancy diagnosis.

It also provides protia food iga, a chronic food intolerance test to identify the foods that do not fit, and stay healthy; anitia canine ige, a serum to identify the cause of the allergy; anicheck bovine igg, a colostrum for feeding calves.

In addition, the company provides genedania, a kit for the detection of nucleic acid from SARS-CoV-2.

Further, it offers 2-D electrophoresis, mass spectrometry, post translational, and protein services. The company was formerly known as ProteomeTech Inc. and changed its name to Protia Inc. in November 2023.

Protia Inc. was founded in 2000 and is based in Seoul, South Korea.

Protia Inc.
Country South Korea
Founded 2000
Industry In Vitro and In Vivo Diagnostic Substances
CEO Kook Jin Lim

Contact Details

Address:
A-702, 401 Yangcheon-ro
Seoul, 07528
South Korea
Phone 82 2 6968 5288
Website protia.co.kr

Stock Details

Ticker Symbol 303360
Exchange KOSDAQ
Reporting Currency KRW
SIC Code 2835

Key Executives

Name Position
Kook Jin Lim Chief Executive Officer